Vor Biopharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Vor Biopharma Inc. (VOR) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents81.9531.3657.71119.8048.54
Short-Term Investments9.98105.82172.5487.670.00
Cash & Short-Term Investments91.93137.18230.25207.4748.54
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.383.154.372.090.10
Total Current Assets96.51140.80236.95214.4049.11
Non-Current Assets
Property, Plant & Equipment (Net)41.5950.1057.0822.5221.85
Other Non-Current Assets4.807.235.345.674.96
Total Non-Current Assets46.3857.3262.4228.1926.80
Total Assets142.89198.13299.37242.5975.91
Current Liabilities
Accounts Payable1.510.821.771.555.89
Short-Term Debt4.220.000.000.000.00
Accrued Liabilities6.6810.938.081.546.26
Other Current Liabilities0.360.320.541.050.72
Total Current Liabilities18.6115.5713.1210.1510.21
Non-Current Liabilities
Long-Term Debt27.6231.8335.6416.1717.43
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities27.6231.8335.6416.17124.77
Total Liabilities46.2347.4048.7626.33134.97
Stockholders' Equity
Common Stock0.010.010.010.000.00
Retained Earnings-456.99-340.08-222.22-130.12-61.22
Accumulated Other Comprehensive Income0.02-0.08-0.770.000.00
Additional Paid-in Capital553.62490.87473.59346.382.16
Shares Outstanding6.243.393.301.860.00
Total Stockholders' Equity96.66150.72250.61216.26-59.07
Total Liabilities & Equity142.89198.13299.37242.5975.91